Novartis to acquire UK-based ocular gene therapy company

  • 📰 eNCA
  • ⏱ Reading Time:
  • 15 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 51%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

[BUSINESS] Novartis to acquire UK-based ocular gene therapy company

Novartis will make an upfront payment of $800-million to acquire all of the outstanding share capital of the company, as well as potential additional milestone payments of up to $700-million, it said in a statement.

Gyroscope Therapeutics has been developing a one-time gene therapy to treat an age-related condition known as geographic atrophy, which causes lesions on the retina and can cause blindness, it said.Novartis said the transaction's closing was still subject to regulatory approvals.

 

コメントありがとうございます。コメントは審査後に公開されます。
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 49. in JP

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

MAS Real Estate sells UK investment property for €45.2mProceeds of sale after taxes and mandatory settlements of senior debt facilities will be used for acquisitions
ソース: BDliveSA - 🏆 12. / 63 続きを読む »